7-Suggestion: Where genomic testing was performed for an indication other than to investigate kidney disease, a secondary finding of pathogenic variants in the COL4A5 gene and cases with two or more pathogenic variants in COL4A3/COL4A4 should be reported. (Grade C, moderate). Here, COL4A5 is linked to kidney disorder.